News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ReGen Biologics, Inc. (RGBI) Employs Industry Veteran To Lead Training


4/28/2009 11:58:47 AM

HACKENSACK, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBO), which manufactures and distributes a meniscus implant for use in arthroscopic surgery to address the most common form of knee injury, has hired an executive with nearly two decades of orthopaedics experience to lead the company’s surgeon education and training program.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES